Mapping the active site of vaccinia virus RNA triphosphatase Journal Article


Authors: Gong, C.; Shuman, S.
Article Title: Mapping the active site of vaccinia virus RNA triphosphatase
Abstract: The RNA triphosphatase component of vaccinia virus mRNA capping enzyme (the product of the viral D1 gene) belongs to a family of metal-dependent phosphohydrolases that includes the RNA triphosphatases of fungi, protozoa, Chlorella virus, and baculoviruses. The family is defined by two glutamate-containing motifs (A and C) that form the metal-binding site. Most of the family members resemble the fungal and Chlorella virus enzymes, which have a complex active site located within the hydrophilic interior of a topologically closed eight-stranded β barrel (the so-called "triphosphate tunnel"). Here we queried whether vaccinia virus capping enzyme is a member of the tunnel subfamily, via mutational mapping of amino acids required for vaccinia triphosphatase activity. We identified four new essential side chains in vaccinia D1 via alanine scanning and illuminated structure-activity relationships by conservative substitutions. Our results, together with previous mutational data, highlight a constellation of six acidic and three basic amino acids that likely compose the vaccinia triphosphatase active site (Glu37, Glu39, Arg77, Lys107, Glu126, Asp159, Lys161, Glu192, and Glu194). These nine essential residues are conserved in all vertebrate and invertebrate poxvirus RNA capping enzymes. We discerned no pattern of clustering of the catalytic residues of the poxvirus triphosphatase that would suggest structural similarity to the tunnel proteins (exclusive of motifs A and C). We infer that the poxvirus triphosphatases are a distinct lineage within the metal-dependent RNA triphosphatase family. Their unique active site, which is completely different from that of the host cell's capping enzyme, recommends the poxvirus RNA triphosphatase as a molecular target for antipoxviral drug discovery. © 2003 Elsevier Science (USA). All rights reserved.
Keywords: controlled study; unclassified drug; mutation; nonhuman; animals; triphosphatase; rna triphosphatase; enzyme activity; acid anhydride hydrolases; structure activity relation; vertebrata; gene mapping; amino acid sequence; molecular sequence data; sequence homology, amino acid; kinetics; rna, messenger; sequence alignment; vaccinia virus; amino acid; binding sites; alanine; enzyme structure; glutamic acid; aspartic acid; protozoa; fungi; lysine; arginine; chlorella virus; enzyme active site; enzyme; invertebrata; poxvirus; poxviridae; rna capping; virus gene; nucleotidyltransferases; priority journal; article
Journal Title: Virology
Volume: 309
Issue: 1
ISSN: 0042-6822
Publisher: Elsevier Inc.  
Date Published: 2003-04-25
Start Page: 125
End Page: 134
Language: English
DOI: 10.1016/s0042-6822(03)00002-3
PUBMED: 12726733
PROVIDER: scopus
DOI/URL:
Notes: Export Date: 12 September 2014 -- Source: Scopus
Altmetric
Citation Impact
BMJ Impact Analytics
MSK Authors
  1. Stewart H Shuman
    546 Shuman